- Home
- JNVR vs EVOK Comparison
JNVR vs EVOK Comparison
Compare JNVR & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- EVOK
- Stock Information
- Founded
- JNVR 2018
- EVOK 2007
- Country
- JNVR United States
- EVOK United States
- Employees
- JNVR N/A
- EVOK N/A
- Industry
- JNVR Finance: Consumer Services
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- EVOK Health Care
- Exchange
- JNVR Nasdaq
- EVOK Nasdaq
- Market Cap
- JNVR 5.1M
- EVOK 4.3M
- IPO Year
- JNVR 2023
- EVOK 2013
- Fundamental
- Price
- JNVR $0.49
- EVOK $4.50
- Analyst Decision
- JNVR
- EVOK
- Analyst Count
- JNVR 0
- EVOK 0
- Target Price
- JNVR N/A
- EVOK N/A
- AVG Volume (30 Days)
- JNVR 1.2M
- EVOK 1.2M
- Earning Date
- JNVR 11-06-2024
- EVOK 11-07-2024
- Dividend Yield
- JNVR N/A
- EVOK N/A
- EPS Growth
- JNVR N/A
- EVOK N/A
- EPS
- JNVR N/A
- EVOK N/A
- Revenue
- JNVR $1,820,969.00
- EVOK $8,617,036.00
- Revenue This Year
- JNVR N/A
- EVOK $124.10
- Revenue Next Year
- JNVR N/A
- EVOK $75.70
- P/E Ratio
- JNVR N/A
- EVOK N/A
- Revenue Growth
- JNVR N/A
- EVOK 100.35
- 52 Week Low
- JNVR $0.42
- EVOK $3.54
- 52 Week High
- JNVR $1.84
- EVOK $17.40
- Technical
- Relative Strength Index (RSI)
- JNVR 39.92
- EVOK 40.54
- Support Level
- JNVR $0.43
- EVOK $4.28
- Resistance Level
- JNVR $0.69
- EVOK $4.79
- Average True Range (ATR)
- JNVR 0.09
- EVOK 0.45
- MACD
- JNVR -0.01
- EVOK -0.13
- Stochastic Oscillator
- JNVR 16.78
- EVOK 22.82
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.